Latest information as of Friday 3rd November:

We have submitted an application to the MHRA to import Kavigale for named patients. We will begin to offer this treatment from November on Wednesdays and Saturdays, when our clinic will be closed to the general public.

‍

Price for Consultation is £250 (unless having undertaken an appointment with the Vesey for assessment previously and without any medical changes.

‍

Price for infusion is £4000

‍

Sipavibart, sold under the brand name Kavigale, is a medication used for the prevention of COVID-19 in people who are immunocompromised. Sipavibart is a recombinant human IgG1 monoclonal antibody that provides passive immunization against SARS-CoV-2 by binding its spike protein receptor binding domain.

Sipavibart was authorised for medical use in the European Union in January 2025.

Medical uses

Sipavibart is indicated for the pre-exposure prophylaxis of COVID-19 in people aged twelve years of age and older weighing at least 40 kilograms (88 lb) and who are immunocompromised due to a medical condition or receipt of immunosuppressive treatments

‍